Imago Biosciences Inc

Company Profile

Imago Biosciences Inc had its IPO on 2021-07-16 under the ticker symbol IMGO.

The company operates in the Healthcare sector and Biotechnology & Medical Research industry. Imago Biosciences Inc has a staff strength of 41 employees.

Stock update

Shares of Imago Biosciences Inc opened at $35.95 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $35.95 - $35.97, and closed at $35.95.

This is a -0.03% slip from the previous day's closing price.

A total volume of 0 shares were traded at the close of the day’s session.

In the last one week, shares of Imago Biosciences Inc have increased by +0.08%.

Imago Biosciences Inc's Key Ratios

Imago Biosciences Inc has a market cap of $1.22 billion, indicating a price to book ratio of 7.042 and a price to sales ratio of 0.

In the last 12-months Imago Biosciences Inc’s revenue was $0 with a gross profit of $0 and an EBITDA of $-62885000. The EBITDA ratio measures Imago Biosciences Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Imago Biosciences Inc’s operating margin was 0% while its return on assets stood at -18.55% with a return of equity of -30.74%.

In Q3, Imago Biosciences Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Imago Biosciences Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-2.163 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Imago Biosciences Inc’s profitability.

Imago Biosciences Inc stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of -16.493. Its price to sales ratio in the trailing 12-months stood at 0.

Imago Biosciences Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$186.46 million

Total Liabilities

$13.84 million

Operating Cash Flow

$-3288000.00

Capital Expenditure

$0

Dividend Payout Ratio

0%

Imago Biosciences Inc ended 2024 with $186.46 million in total assets and $0 in total liabilities. Its intangible assets were valued at $186.46 million while shareholder equity stood at $172.62 million.

Imago Biosciences Inc ended 2024 with $0 in deferred long-term liabilities, $13.84 million in other current liabilities, 3000.00 in common stock, $-159564000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $7.29 million and cash and short-term investments were $178.41 million. The company’s total short-term debt was $0 while long-term debt stood at $0.

Imago Biosciences Inc’s total current assets stands at $182.04 million while long-term investments were $0 and short-term investments were $171.12 million. Its net receivables were $0 compared to accounts payable of $3.90 million and inventory worth $0.

In 2024, Imago Biosciences Inc's operating cash flow was $-3288000.00 while its capital expenditure stood at $0.

Comparatively, Imago Biosciences Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$35.95

52-Week High

$36.09

52-Week Low

$13.912

Analyst Target Price

$36

Imago Biosciences Inc stock is currently trading at $35.95 per share. It touched a 52-week high of $36.09 and a 52-week low of $36.09. Analysts tracking the stock have a 12-month average target price of $36.

Its 50-day moving average was $27.96 and 200-day moving average was $18.91 The short ratio stood at 0.59 indicating a short percent outstanding of 0%.

Around 372.5% of the company’s stock are held by insiders while 10012.8% are held by institutions.